Definition of analgesia
Physiology of pain
Classification of analgesia
Etymology: Derived from Greek — "an-" (without) + "algesia" (pain) → "painlessness"
Definition: Selective relief of pain without significant alteration of consciousness, differentiating it from general anesthesia.
Mechanism of Action: Acts centrally, peripherally, or both; targets CNS to modulate or interrupt pain pathways.
Unpleasant sensory/emotional experience due to actual or potential tissue damage.
Importance of Pain Management:
Prevents perioperative stress (e.g., tachycardia, hypertension)
Reduces chronic post-surgical pain risk
Enhances patient comfort, recovery, satisfaction
STEP 1: TRANSDUCTION
Injury causes chemical release (bradykinin, prostaglandins, H⁺, K⁺) → activates nociceptors (pain receptors)
Nerve fibers:
Aδ fibers: Sharp, fast pain
C fibers: Dull, slow pain
Prostaglandins & Substance P lower nociceptor threshold (sensitization)
STEP 2: TRANSMISSION
Signal travels from periphery → dorsal horn (spinal cord) → thalamus
Neurotransmitters: Glutamate (AMPA & NMDA receptors), Substance P
STEP 3: MODULATION
Brainstem sends inhibitory signals (serotonin, norepinephrine, endogenous opioids)
Can suppress or enhance pain
STEP 4: PERCEPTION
Thalamus → Somatosensory cortex (pain location)
Limbic system (emotional aspect)
Prefrontal cortex (awareness)
Cardiovascular System (CVS):
Tachycardia, increased BP, increased SVR and coronary resistance
Respiratory System (RS):
Reduced tidal volume, FRC → hypoxemia, hypercapnia
Poor cough, secretion retention
Gastrointestinal Tract (GIT):
Decreased motility, gastric stasis, paralytic ileus
Increased sphincter tone and secretions
Genitourinary Tract (GUT):
Difficulty in micturition
Catabolic metabolism → weight loss, negative nitrogen balance
Fear, anxiety, anger, resentment
Sleep deprivation
Depression, helplessness
By Drug Type:
Opioid (e.g., morphine)
Non-opioid (e.g., NSAIDs)
By Site of Action:
Peripheral Nerve: NSAIDs, paracetamol, local anesthetics
Dorsal Horn: Opiates, ketamine
Descending Inhibitory Tracts: Paracetamol, tramadol, clonidine
Brain: Opiates, TCA, clonidine
MOA: Opioid receptor agonists; activate descending inhibitory pathways and reduce peripheral nociception
Receptor Types and Effects:
μ (Mu): Analgesia, euphoria, respiratory depression, constipation
κ (Kappa): Analgesia, dysphoria, sedation
δ (Delta): Peripheral analgesia, GI effects
Endogenous Opioids: β-endorphins, enkephalins, dynorphins (called opiopeptins)
Receptor Locations and Effects:
Brainstem: Resp. depression, nausea, pupil constriction
Thalamus: Emotional pain suppression
Spinal cord: Pain signal attenuation
Hypothalamus: Neuroendocrine effects
Limbic system: Emotional behavior
Periphery: Substance P inhibition
By Origin:
Natural: Morphine, codeine
Semisynthetic: Heroin, buprenorphine
Synthetic: Fentanyl, pethidine
By Efficacy:
High: Morphine, fentanyl, methadone
Moderate: Codeine, oxycodone, pentazocine
CNS: Analgesia, sedation, respiratory depression, miosis
GIT: Constipation, biliary spasm
CVS: Vasodilation, bradycardia
Immune: Suppression with long use
Other: Piloerection, sweating
Dose:
Pre-med: 0.05–0.1 mg/kg
Anaesthesia: IV 0.05–0.2 mg/kg
Max daily: 1.5 mg/kg
Pediatric Dose: 0.2 mg/kg
Side Effects: Histamine release (hypotension), apnea, bradycardia, constipation, delayed gastric emptying
Synthetic opioid (phenylpiperidine class)
Dose: 0.5–2 mg/kg IV/IM QID
Caution: Produces norpethidine (toxic metabolite)
Contraindications: Renal failure, hypovolemia, MAOI use
Potent synthetic opioid (100x morphine)
Dose: 0.5–100 mcg/kg
Routes: IV, transdermal, epidural, spinal
Duration: 30–45 min
Use: Acute pain, short procedures
Dual action: μ-receptor agonist + inhibits serotonin/norepinephrine reuptake
Dose:
Oral: 50–100 mg q4–6h (max 400 mg/day)
IV/IM: Bolus 100 mg, max 600 mg/day
Not for: <12 yrs, MAOI use, pregnancy/lactation
Advantage: Minimal respiratory depression
NSAIDs:
MOA: Inhibit COX-1 and COX-2
Side Effects: GI bleeding, AKI
Types:
Non-selective: Aspirin, ibuprofen, diclofenac
COX-2 selective: Celecoxib, parecoxib
Paracetamol:
MOA: Possibly inhibits COX-3
Use: Analgesic, antipyretic
Caution: Hepatotoxic in overdose
Class: NMDA antagonist, dissociative anesthetic
Analgesic Use:
Effective in opioid-resistant pain
Opioid-sparing
Maintains respiration, BP
Contraindications: Renal failure, psychosis, raised ICP
Side Effects: Emergence reactions (can be reduced with midazolam)
(Cancer Pain but also applicable to acute pain)
Step 1: Non-opioids ± non-drug methods
Step 2: Mild opioids (e.g., codeine)
Step 3: Strong opioids (e.g., morphine)
Principle: Give by the clock (scheduled), not on demand
Simple Pain:
Paracetamol 1g QDS (IV/PO/PR)
NSAIDs: Diclofenac 50mg TDS, Ibuprofen 400mg TDS
Moderate Pain:
Codeine 30–60mg QDS PRN
Tramadol 50–100mg QDS
Severe Pain:
Morphine: PO 10mg q4h, IV 5–10mg q4h
Pethidine: IM/SC 25–100mg q3h; IV 25–50mg
More in the document above.
END